Article Details

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Rating of "Buy" by Analysts

Retrieved on: 2021-07-03 09:56:15

Tags for this article:

Click the tags to see associated articles and topics

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,257,640 shares of the biotechnology company's stock worth $144,541,000 after acquiring an additional 288,920 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up